BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hepatitis
,
Lymphocyte
,
Laryngoscope
,
Acetaminophen
,
rs6983267
,
MDM2
,
Apoptosis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
pad3
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
No diseases found
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
No compounds found
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
No perturbed genes found
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Melanoma 501-MEL cells with CHD4 and CHD3 siRNA knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
Peptidylarginine Deiminase 3 (PAD3) Is Upregulated by Prolactin Stimulation of CID-9 Cells and Expre…
Padi2/3 Deficiency Alters the Epigenomic Landscape and Causes Premature Differentiation of Mouse Tro…
Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Spec…
Cellular Activity of New Small Molecule Protein Arginine Deiminase 3 (PAD3) Inhibitors.
Anti-peptidyl-arginine deaminase 3 (PAD3) antibodies as a promising marker to measure joint damage i…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Carnosine for Peripheral Arterial Disease Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ